Private equity activity is lagging in Asia across fundraising, investment and exits as a result of political and economic headwinds. But there is still appetite for new managers and strategies
Uncertainty and volatility have plagued Asian private equity in 2019. From US-China trade tensions and Brexit to a rationalization of unicorn valuations and a revising of growth prospects, a host of political...
Shanghai Kechow Pharma, a Chinese small molecule targeted drug developer, has raised a $45 million Series C round led by Decheng Capital.
Kurt Bjorklund, a co-managing partner at Permira, explains how a sector-focused investment style is becoming indispensable in Asia’s competitive and disruption-prone markets
Baibu, a Chinese B2B trading and services platform for the textiles and fabrics industry, has raised a $300 million Series D round led by DST Global.
Food delivery start-up Delivery Hero has agreed to acquire Korean peer Woowa Brothers in a deal that values the target at $4 billion and will facilitate exits for several private equity investors.